144 related articles for article (PubMed ID: 3191338)
21. DNA flow cytometry in carcinoma of the prostate for diagnosis, prognosis and study of tumor biology.
Tribukait B
Acta Oncol; 1991; 30(2):187-92. PubMed ID: 2029403
[TBL] [Abstract][Full Text] [Related]
22. Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients: impact on time to progression. The European Organization for Research and Treatment of Cancer Genitourinary Group.
van den Ouden D; Tribukait B; Blom JH; Fossa SD; Kurth KH; ten Kate FJ; Heiden T; Wang N; Schroder FH
J Urol; 1993 Aug; 150(2 Pt 1):400-6. PubMed ID: 8326563
[TBL] [Abstract][Full Text] [Related]
23. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
[TBL] [Abstract][Full Text] [Related]
24. DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure.
Borre M; Høyer M; Nerstrøm B; Overgaard J
Prostate; 1998 Sep; 36(4):244-9. PubMed ID: 9719024
[TBL] [Abstract][Full Text] [Related]
25. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
Cowan RA; Harris M; Jones M; Crowther D
Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100
[TBL] [Abstract][Full Text] [Related]
26. Pre- and postoperative DNA ploidy patterns correlated to pT-stage, histological grade and tumour volume in total prostatectomy specimens.
Häggman M; de la Torre M; Brändstedt S; Norlén BJ; Norberg M; Busch C
Scand J Urol Nephrol; 1994 Mar; 28(1):59-66. PubMed ID: 8009195
[TBL] [Abstract][Full Text] [Related]
27. DNA and S-phase fraction analysis by flow cytometry in prostate cancer. Clinicopathologic implications.
Tinari N; Natoli C; Angelucci D; Tenaglia R; Fiorentino B; Di Stefano P; Amatetti C; Zezza A; Nicolai M; Iacobelli S
Cancer; 1993 Feb; 71(4):1289-96. PubMed ID: 8435806
[TBL] [Abstract][Full Text] [Related]
28. Correlation of DNA ploidy and histologic diagnosis from prostate core-needle biopsies: is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens?
Lo J; Kerns BJ; Amling CL; Robertson CN; Layfield LJ
J Surg Oncol; 1996 Sep; 63(1):41-5. PubMed ID: 8841465
[TBL] [Abstract][Full Text] [Related]
29. Near tetraploid prostate carcinoma. Methodologic and prognostic aspects.
Forsslund G; Nilsson B; Zetterberg A
Cancer; 1996 Oct; 78(8):1748-55. PubMed ID: 8859188
[TBL] [Abstract][Full Text] [Related]
30. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
[TBL] [Abstract][Full Text] [Related]
31. Flow-cytometric analysis of the DNA-content in paraffin-embedded tissue from colorectal carcinomas and its prognostic significance.
Baretton G; Gille J; Oevermann E; Löhrs U
Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(2):123-31. PubMed ID: 1675509
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy.
Visakorpi T; Kallioniemi OP; Paronen IY; Isola JJ; Heikkinen AI; Koivula TA
Br J Cancer; 1991 Sep; 64(3):578-82. PubMed ID: 1911201
[TBL] [Abstract][Full Text] [Related]
33. Carcinoma of the anal canal and flow cytometric DNA analysis.
Scott NA; Beart RW; Weiland LH; Cha SS; Lieber MM
Br J Cancer; 1989 Jul; 60(1):56-8. PubMed ID: 2803916
[TBL] [Abstract][Full Text] [Related]
34. Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome.
Fordham MV; Burdge AH; Matthews J; Williams G; Cooke T
Br J Surg; 1986 May; 73(5):400-3. PubMed ID: 3708298
[TBL] [Abstract][Full Text] [Related]
35. Correlation of prostate cancer nuclear deoxyribonucleic acid, size, shape and Gleason grade with pathological stage at radical prostatectomy.
Epstein JI; Pizov G; Steinberg GD; Carter HB; Pitcock R; Armas OA; Partin A; Walsh PC
J Urol; 1992 Jul; 148(1):87-91. PubMed ID: 1613888
[TBL] [Abstract][Full Text] [Related]
36. Deoxyribonucleic acid content and survival rates of patients with transitional cell carcinoma of the bladder.
al-Abadi H; Nagel R
J Urol; 1994 Jan; 151(1):37-42. PubMed ID: 8254829
[TBL] [Abstract][Full Text] [Related]
37. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
[TBL] [Abstract][Full Text] [Related]
38. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
39. S-phase fraction related to prognosis in localised prostate cancer. No specific significance of chromosome 7 gain or deletion of 7q31.1.
Aström L; Weimarck A; Aldenborg F; Delle U; Hanson C; Verbiene I; Danielsson A; Hammarsten J; Köpf I
Int J Cancer; 1998 Dec; 79(6):553-9. PubMed ID: 9842961
[TBL] [Abstract][Full Text] [Related]
40. Management of localized prostate cancer.
Smith JA
Cancer; 1992 Jul; 70(1 Suppl):302-6. PubMed ID: 1600491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
